Series Overview
About 71 million Americans live with some form of cardiovascular disease, which causes more than 37% of all deaths in the United States. As you know, the fields of cardiology and cardiac surgery are constantly evolving to combat heart and vascular disease. Cleveland Clinic Heart and Vascular Institute staff are pleased to present the latest advances and techniques in an interactive continuing medical education series.

From novel pharmaceuticals and device-based therapy to heart transplantation, new developments and applications are emerging. Are you interested in learning more about the application and potential of breakthroughs such as three-dimensional imaging, drug-eluting stents and gene therapy? Would your practice benefit from greater knowledge of the latest minimally invasive surgery and new, nonsurgical percutaneous approaches to cardiovascular disease?

Emerging Therapies in Heart Disease CME Series offers a convenient opportunity to gain knowledge of new advancements in atrial fibrillation, aortic valve disease, coronary artery disease, heart failure and mitral valve disease. This interactive series offers presentations and discussions of patient history and new surgical advancement coupled with a live interactive discussion with program faculty. Cardiologists and cardiac surgeons will take away practical knowledge to assist in developing strategies to optimize patient outcomes.

Objectives

1. Review the latest treatment modalities and innovations for cardiovascular disease.
2. Recognize the innovations in medical management and team-based approaches.
3. Explain the latest surgical treatments, including minimally invasive surgery, the maze procedure and newer, less invasive approaches.
4. Discuss new imaging and diagnostic modalities.

For more information, please contact
UNITECH Communications^®
800/238-6750
216/297-7330